Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans

NCT07492173 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor Cancer

Interventions

DRUG: Trifluridine and Tipiracil Tablets
DRUG: Lonsurf®

Sponsor

Shandong New Time Pharmaceutical Co., LTD